Cargando…
Effectiveness of a Nutritional Mobile Application for Management of Hyperphosphatemia in Patients on Hemodialysis: A Multicenter Open-Label Randomized Clinical Trial
This study aims to determine the effectiveness of a phosphate mobile app (PMA), MyKidneyDiet-Phosphate Tracker ©2019, on hemodialysis (HD) patients with hyperphosphatemia. A multicenter, open-label, randomized controlled trial design allowed randomization of patients with hyperphosphatemia to either...
Autores principales: | Teong, Lee-Fang, Khor, Ban-Hock, Ng, Hi-Ming, Sahathevan, Sharmela, Purba, Kristo Radion, Narayanan, Sreelakshmi Sankara, Gafor, Abdul Halim Abdul, Goh, Bak-Leong, Bee, Boon-Cheak, Yahya, Rosnawati, Bavanandan, Sunita, Wahab, Zaimi, Mazlan, Sadanah Aqashiah, Chinna, Karuthan, Morad, Zaki, Daud, Zulfitri Azuan Mat, Karupaiah, Tilakavati |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224811/ https://www.ncbi.nlm.nih.gov/pubmed/35743746 http://dx.doi.org/10.3390/jpm12060961 |
Ejemplares similares
-
A Mobile App for Triangulating Strategies in Phosphate Education Targeting Patients with Chronic Kidney Disease in Malaysia: Development, Validation, and Patient Acceptance
por: Teong, Lee-Fang, et al.
Publicado: (2022) -
Efficacy of Nutritional Interventions on Inflammatory Markers in Haemodialysis Patients: A Systematic Review and Limited Meta-Analysis
por: Khor, Ban-Hock, et al.
Publicado: (2018) -
Muscle Status Response to Oral Nutritional Supplementation in Hemodialysis Patients With Protein Energy Wasting: A Multi-Center Randomized, Open Label-Controlled Trial
por: Sahathevan, Sharmela, et al.
Publicado: (2021) -
Blood Fatty Acid Status and Clinical Outcomes in Dialysis Patients: A Systematic Review
por: Khor, Ban-Hock, et al.
Publicado: (2018) -
Association of dietary patterns with serum phosphorus in maintenance haemodialysis patients: a cross-sectional study
por: Khor, Ban-Hock, et al.
Publicado: (2020)